MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2024 International Congress

September 27-October 1, 2024. Philadelphia, PA.

View by Title View Sessions
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Blood-brain Barrier Breakdown in Dementia with Lewy Bodies

    ZC. Chen, J. Gan, Y. Ji (Beijing, China)

  • Body Mass Index as a Possible Poor Prognostic Factor in Motor and Postural Condition Through the Evaluation of MDS-UPDRS 3.3 – 3.18 in Patients with Parkinson’s.

    C. álvarez-Hernández, R. Baños-Betancourt, K. Velazquez-Roman, G. Rivera-Monroy, A. Guerra-Anzaldo, W. Moguel-Cardín, A. Domínguez-García, D. Romero-Terán, A. Regalado-Mustafá, J. Delgado-Uriarte, N. Moreno-Aldama, A. Uribe Leon, M. Unda-Mcfarlane, A. Cervantes-Arriaga, M. Rodriguez-Violante, D. Luna-Escamilla, K. Gonzalez-Rosas, U. Ugalde-Miranda, F. Moralez-Gonzalez, M. Cabrera-Jimenez (Mexico City, Mexico)

  • Boosting Clinical Trial Power in Parkinson’s Disease with AI-Generated Digital Twins

    C. Murray, C. Kusiak, A. Vanderbeek, D. Bertolini, E. Tramel (San Francisco, USA)

  • Boosting Parkinson’s Disease Diagnosis: How Training Ethiopian Healthcare Workers and Enhancing Community Level Awareness Led to a Surge in Case Identification

    MRS. Yinesu (Addis Ababa, Ethiopia)

  • Botulinum Toxin A Usage in Movement Disorder Division: A Retrospective Chart Review

    S. Shaikh, R. Figari Jordan (Charlottesville, USA)

  • Botulinum Toxin and Deep Brain Stimulation in Dystonia

    J. Souza, A. Falcone, R. Barbosa, M. Soares, R. Munhoz, M. Farah, T. Capato, S. Casagrande, M. Cordellini, G. Micheli, J. Limongi, E. Barbosa, C. Listik, R. Cury (Sao Paulo, Brazil)

  • Brain De-Ironization with Nasal Spray of Iron Chelator in Treatment of Multiple System Atrophy, a Case Trial

    A. Amoushahi, A. Sahebkar, P. Moeini, N. Chitsaz (Isfahan, Islamic Republic of Iran)

  • Brainstem Monoaminergic Degeneration, Cognition, and Autonomic Symptom Progression in Early Parkinson’s Disease

    KA. Woo, SY. Kim, HY. Choi, JH. Shin, HJ. Kim (Seoul, Republic of Korea)

  • Breaking Barriers to Offer Evidence-Based Services for Patients with Parkinson’s Disease in South Africa

    S. Govender, S. Haffejee (Johannesburg, South Africa)

  • Bright Light Therapy: A Novel Non-Pharmacological Approach to Parkinson’s Disease

    QK. Lv, YR. Sun, F. Wang, CF. Liu (Suzhou, China)

  • « Previous Page
  • 1
  • …
  • 25
  • 26
  • 27
  • 28
  • 29
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley